(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...

On STAT's podcast, hear about what happened with AbbVie's schizophrenia drug, Amgen's obesity drug and what might happen at ...

Amgen’s stock fell 7% after an analyst posted a note on MariTide’s influence on bone density which was noticed in a data ...

Analysts have set 12-month price targets for Amgen, revealing an average target of $349.0, a high estimate of $405.00, and a ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone mineral density, a ...

Begin your TipRanks Premium journey today. Amgen (AMGN) Company Description: Founded in 1980, California-based Amgen, Inc. is one of the world’s leading biotechnology companies, which is engaged in ...

An analyst note raising questions about Amgen’s MariTide triggered a stock sell-off Tuesday. Elsewhere, Roche and Novartis ...

Every step of the way, Rose Booker, formally of the Durham Catholic District School Board, has worked tirelessly to make sure the youth in her community have the tools they need to quickly respond to ...

Phase 1 data. "As previously stated, Amgen does not see an association between the administration of MariTide and bone mineral density ...

REYKJAVIK, Iceland, Nov. 12, 2024 /CNW/ -- New study from deCODE genetics/Amgen highlights the importance of BMI in ...

Inc. (US), Amgen Inc. (US)" Browse 258 market data Tables and 48 Figures spread through 292 Pages and in-depth TOC on ...

SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...